Tower Research Capital LLC (Trc) Hutchmed (China) LTD Transaction History
Tower Research Capital LLC (Trc)
- $5.8 Billion
- Q2 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Hutchmed (China) LTD stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,694 shares of HCM stock, worth $30,492. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,694
Previous 4,658
63.63%
Holding current value
$30,492
Previous $78,000
62.82%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding HCM
# of Institutions
66Shares Held
8.25MCall Options Held
3.8KPut Options Held
2.4K-
Schroder Investment Management Group London, X03.02MShares$54.4 Million0.06% of portfolio
-
Allianz Asset Management Gmb H Munich, 2M1.5MShares$27 Million0.04% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.15MShares$20.7 Million0.33% of portfolio
-
Acadian Asset Management LLC Boston, MA389KShares$7 Million0.02% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny358KShares$6.44 Million0.0% of portfolio
About HUTCHMED (China) Ltd
- Ticker HCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 172,955,008
- Market Cap $3.11B
- Description
- HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...